Aurigene Pharmaceutical Services
Aurigene Pharmaceutical Services is a leading Contract Research, Development and Manufacturing Organization (CDMO) dedicated to providing comprehensive solutions to the pharmaceutical industry.
Description
Aurigene Pharmaceutical Services is a leading contract research, development, and manufacturing organisation (CRDMO) providing integrated services to global pharmaceutical and biotech companies.
With over 25 years of experience, Aurigene offers end-to-end solutions across the lifecycle of drug development, from discovery to commercialisation. The company specialises in small and large molecule discovery, development, and manufacturing, supporting both chemistry and biology services. Their flexible offerings include integrated drug discovery, AI drug discovery, and biologics solutions. Aurigene has established long-term partnerships with top pharmaceutical companies.
Key Products and Services
- Small Molecule Discovery (Chemistry & Biology)
- Small Molecule CDMO Services
- Biologics Discovery and Development
- Integrated Drug Discovery (IDD)
- AI Drug Discovery (AIDD)
- DNA Encoded Library (DEL) Screening Services
- CADD and Bioinformatics
- Commercial Manufacturing for Small and Large Molecules
Aurigene’s commitment to quality, compliance, and environmental sustainability, combined with its robust expertise, makes it a valuable partner for companies aiming to accelerate drug development.